85 related articles for article (PubMed ID: 3090175)
41. Interaction of a nuclear factor derived from the trophoblast cell line BeWo with the HLA-G gene.
Kimura T; Koyama M; Saji F
Int J Gynaecol Obstet; 1998 Oct; 63(1):67-8. PubMed ID: 9849716
[No Abstract] [Full Text] [Related]
42. Lack of expression of HLA antigens on choriocarcinoma cell lines.
Jones EA; Bodmer WF
Tissue Antigens; 1980 Aug; 16(2):195-202. PubMed ID: 7008252
[TBL] [Abstract][Full Text] [Related]
43. The role of endoplasmic reticulum aminopeptidase 2 in modulating immune detection of choriocarcinoma.
Warthan MD; Washington SL; Franzese SE; Ramus RM; Kim KR; York TP; Stratikos E; Strauss JF; Lee ED
Biol Reprod; 2018 Mar; 98(3):309-322. PubMed ID: 29324974
[TBL] [Abstract][Full Text] [Related]
44. Serological analysis of cell surface antigens in choriocarcinoma cell lines.
Saito M; Goto S; Kato S; Okamoto T; Tomoda Y
Am J Reprod Immunol; 1989 Mar; 19(3):114-9. PubMed ID: 2765138
[TBL] [Abstract][Full Text] [Related]
45. An immunohistological study of HLA antigen expression by gestational choriocarcinoma.
Sunderland CA; Sasagawa M; Kanazawa K; Stirrat GM; Takeuchi S
Br J Cancer; 1985 Jun; 51(6):809-14. PubMed ID: 2408648
[TBL] [Abstract][Full Text] [Related]
46. HLA and trophoblastic disease.
Law HY
Ann Acad Med Singap; 1982 Oct; 11(4):549-54. PubMed ID: 6299166
[TBL] [Abstract][Full Text] [Related]
47. Anti-HLA antibodies detected in the serum of patients with gestational trophoblastic tumors (choriocarcinomas and invasive moles).
Yamashita K; Ishikawa M; Shimizu T; Kuroda M
Gynecol Oncol; 1981 Dec; 12(3):296-301. PubMed ID: 6273268
[No Abstract] [Full Text] [Related]
48. Expression of HLA-DR molecules in human gestational choriocarcinoma cell lines and malignant cell lines.
Takahashi H; Adachi S; Yoshiya N; Suzuki T; Kanazawa K; Takeuchi S
Placenta; 1987; 8(3):293-8. PubMed ID: 3658923
[TBL] [Abstract][Full Text] [Related]
49. [Studies on mixed lymphocyte-tumor cell culture reaction (MLTR) in gynecological malignant tumors by the microplate methods (author's transl)].
Ohno M; Kato M; Kanazawa K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):529-34. PubMed ID: 6453911
[TBL] [Abstract][Full Text] [Related]
50. An immunohistochemical study of colon-ovarian tumor antigen and colon-specific antigen in gynecologic tumors.
Ueda G; Shimizu C; Saito J; Tanaka Y; Inoue M; Tanizawa O
Gynecol Oncol; 1989 Oct; 35(1):90-2. PubMed ID: 2792910
[TBL] [Abstract][Full Text] [Related]
51. [Problems faced in the chemotherapy and immunotherapy of choriocarcinoma].
Goto S; Kasegi S; Hara T; Iwase M; Tanaka TU
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Sep; 33(9):1345-54. PubMed ID: 7196937
[No Abstract] [Full Text] [Related]
52. Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells.
Rote NS; Chang J; Katsuragawa H; Ng AK; Lyden TW; Mori T
Am J Reprod Immunol; 1995 Jan; 33(1):114-21. PubMed ID: 7619225
[TBL] [Abstract][Full Text] [Related]
53. Absence of major histocompatibility complex antigens in choriocarcinoma.
Yamashita K; Nakamura T; Shimizu T
Am J Obstet Gynecol; 1984 Dec; 150(7):896-7. PubMed ID: 6542312
[No Abstract] [Full Text] [Related]
54. Studies on antilymphocyte antibodies in gestational choriocarcinoma.
Kanazawa K; Kajino T; Takeuchi S
Hum Reprod; 1986 Dec; 1(8):519-22. PubMed ID: 2950130
[TBL] [Abstract][Full Text] [Related]
55. The relationship between HLA antibodies and the causal pregnancy in choriocarcinoma.
Lawler SD; Klouda PT; Bagshawe KD
Br J Obstet Gynaecol; 1976 Aug; 83(8):651-5. PubMed ID: 60126
[TBL] [Abstract][Full Text] [Related]
56. [Clinical trial of interferon in gynecologic cancers].
Sekiya S; Iwasawa H; Ishige H; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1241-3. PubMed ID: 4040950
[No Abstract] [Full Text] [Related]
57. Modulation of ovarian carcinoma OV632 antigen by interferons.
Marth C; Müller-Holzner E; Gaugg I; Daxenbichler G; Dapunt O
Oncology; 1992; 49(1):53-7. PubMed ID: 1542495
[TBL] [Abstract][Full Text] [Related]
58. Characterization of antibodies to a placenta-specific antigen cross-reacting with a choriocarcinoma cell line.
Sinha S; Bhattacharya A; Band AH; Gaur A; Strivastava LM; Talwar GP
Am J Reprod Immunol (1980); 1984; 6(3):112-6. PubMed ID: 6517177
[TBL] [Abstract][Full Text] [Related]
59. [The analysis of immunosuppressive substance derived from choriocarcinoma cell lines].
Matsuzaki N
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):481-8. PubMed ID: 6222124
[TBL] [Abstract][Full Text] [Related]
60. Histocompatibility-antigen distribution in patients with cervical and endometrial carcinomas.
Sniecinski I; Haley J; Morgan-Byrne J; Van Nagell J
Gynecol Oncol; 1981 Feb; 11(1):68-74. PubMed ID: 7203164
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
